A Long-Acting Neutralizing Monoclonal ACTH Antibody Blocks Corticosterone and Adrenal Gene Responses in Neonatal Rats
The DOI matches its Crossref record; 67 of the 69 references it cites were found in a registry or an index.
Abstract
The control of steroidogenesis in the neonatal adrenal gland is of great clinical interest. We have previously demonstrated that the postnatal day (PD) 2 rat exhibits a large plasma corticosterone response to hypoxia in the absence of an increase in plasma ACTH measured by RIA, whereas the corticosterone response to exogenous ACTH is intact. By PD8, the corticosterone response to hypoxia is clearly ACTH-dependent. We hypothesized that this apparently ACTH-independent response to hypoxia in the newborn rat is due to an increase in a bioactive, nonimmunoassayable form of ACTH. To evaluate this phenomenon, we pretreated neonatal rats with a novel, specific, neutralizing anti-ACTH antibody (ALD1611) (20 mg/kg or 1 mg/kg IP) on the morning of PD1, PD7, and PD14. Twenty-four hours later, we measured hypoxia- or ACTH-stimulated plasma ACTH and corticosterone. For long-term effects, ALD1611 was given on PD1 and pups were studied on PD8 and PD15. Pretreatment with ALD1611 significantly decreased baseline corticosterone and completely blocked the corticosterone response to hypoxia and exogenous ACTH stimulation at all ages. The effect of 1 mg/kg ALD1611 on PD1 had dissipated by PD15. The decrease in corticosterone in ALD1611-treated pups was associated with decreases in baseline and hypoxia- and ACTH-stimulated adrenal Ldlr, Mrap, and Star mRNA expression at all ages. The adrenal response to hypoxia in the newborn rat is ACTH-dependent, suggesting the release of nonimmunoassayable, biologically active forms of ACTH. ALD1611 is useful as a tool to attenuate stress-induced, ACTH-dependent adrenal steroidogenesis in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When added to HC 20 mg/d, 6 days of treatment with 100-250 mg/d of abiraterone acetate normalized androstenedione in 6 adult women (496) with parallel reductions in testosterone, androgen metabolites, and 11-oxoandrogens (497).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [497]
In the citing paper
“Abiraterone acetate therapy can cause DOC accumulation and consequent hypertension and/or hypokalemia in patients with prostate cancer via CYP21A2-mediated 21hydroxylation of intra-adrenal progesterone (497), however, this conversion cannot occur in patients with classic CAH (497).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [497]
In the citing paper
“ALD1613 (Alder BioPharmaceuticals, USA) is a specific, high-affinity, long-acting humanized, neutralizing, monoclonal antibody to ACTH that has been tested in preclinical studies134,135.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [135]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 2×
“Fragmentation spectra were matched to protein sequences in a rodent database using SEQUEST (58).”
MethodOntogeny of the Stress Response in the Rat: Role of the Pituitary and the Hypothalamus*
WALKER, C.-D., PERRIN, M., VALE, W., & RIVIER, C. (1986) · Endocrinology · doi:10.1210/endo-118-4-1445 · Cited by 309
Levine, S., Huchton, D. M., Wiener, S. G., & Rosenfeld, P. (1991) · Developmental Psychobiology · doi:10.1002/dev.420240803 · Cited by 304
Effects of early life stress on adult male aggression and hypothalamic vasopressin and serotonin.
Veenema, A. H., Blume, A., Niederle, D., Buwalda, B., & Neumann, I. D. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05045.x · Cited by 271
Prophylaxis Against Early Adrenal Insufficiency to Prevent Chronic Lung Disease in Premature Infants
Watterberg, K. L., Gerdes, J. S., Gifford, K. L., & Lin, H.-M. (1999) · Pediatrics · doi:10.1542/peds.104.6.1258 · Cited by 256
WALKER, C.-D., SCRIBNER, K. A., CASCIO, C. S., & DALLMAN, M. F. (1991) · Endocrinology · doi:10.1210/endo-128-3-1385 · Cited by 255 · cited 4×
“First Published Online 5 June 2019 Abbreviations: HPA, hypothalamic–pituitary–adrenal; MC2R, melanocortin 2 receptor; PD, postnatal day; SC, subcutaneously; SHRP, stress hyporesponsive period. doi: 10.1210/en.2019-00117 Endocrinology, July 2019, 160(7):1719–1730 https://academic.oup.com/endo 1719 D ow nloaded from htt…”
BackgroundInfluential
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia
Prete, A., Auchus, R. J., & Ross, R. J. (2022) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 46
Novel treatments for congenital adrenal hyperplasia
Schröder, M. A. M., & der Grinten, H. L. C. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09717-w · Cited by 34
Gehrand, A. L., Phillips, J. M., Malott, K., & Raff, H. (2020) · Endocrinology · doi:10.1210/endocr/bqaa085 · Cited by 12
Self-citation
Metadata
- Authors
- Gehrand, A. L., Phillips, J., Malott, K., & Raff, H.
- Affiliations
- Aurora St. Luke's Medical Center (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Raff, Hershel
- ORCID
- Raff, Hershel
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2019-06-05
- Volume
- 160
- Issue
- 7
- Pages
- 1719-1730
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2948090243
- Cited by
- 21
- References
- 69
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 1
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Aurora Research Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- ACTH, neutralizing monoclonal antibodies, corticosterone, adrenal steroidogenesis, neonatal adrenal gland, hypoxia, LDL receptor, MRAP, stars, stress response, postnatal development
- MeSH terms
- Steroidogenic Acute Regulatory Protein, Adrenal Glands, Adrenocorticotropic Hormone, Animals, Animals, Newborn, Hypoxia, Antibodies, Monoclonal, Corticosterone, Female, Hypothalamo-Hypophyseal System, Male, Phosphoproteins, Pituitary-Adrenal System, Receptors, LDL, Rats, Sprague-Dawley, Rats, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Long-Acting Neutralizing Monoclonal ACTH Antibody Blocks Corticosterone and Adrenal Gene Responses in Neonatal Rats. https://app.cochat.ai/papers/10.1210/en.2019-00117
- The paper
- Gehrand, A. L., Phillips, J., Malott, K., & Raff, H. (2019). A Long-Acting Neutralizing Monoclonal ACTH Antibody Blocks Corticosterone and Adrenal Gene Responses in Neonatal Rats. Endocrinology. https://doi.org/10.1210/en.2019-00117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.